PT  - JOURNAL ARTICLE
AU  - Ahmad Sedaghat
AU  - Amir Mosavi
TI  - Predicting Trends of Coronavirus Disease (COVID-19) Using SIRD and Gaussian-SIRD Models
AID  - 10.1101/2020.11.29.20240499
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.11.29.20240499
4099  - http://medrxiv.org/content/early/2020/11/30/2020.11.29.20240499.short
4100  - http://medrxiv.org/content/early/2020/11/30/2020.11.29.20240499.full
AB  - Eruption of COVID-19 patients in 215 countries worldwide have urged for robust predictive methods that can detect as early as possible size and duration of the contagious disease and also providing precision predictions. In many recent literatures reported on COVID-19, one or more essential parts of such investigation were missed. One of crucial elements for any predictive method is that such methods should fit simultaneously as many data as possible; these data could be total infected cases, daily hospitalized cases, cumulative recovered cases and deceased cases and so on. Other crucial elements include sensitivity and precision of such predictive methods on amount of data as the contagious disease evolved day by day. To show importance of these aspects, we have evaluated the standard SIRD model and a newly introduced Gaussian-SIRD model on development of COVID-19 in Kuwait. It is observed that SIRD model quickly pick up main trends of COVID-19 development; but Gaussian-SIRD model provides precise prediction at longer period of time.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNO clinical trialFunding Statementno fundAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Obuda UniversityAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData Online available here: https://www.worldometers.info/coronavirus/ https://www.worldometers.info/coronavirus/ https://www.worldometers.info